Difficulty: Medium
Average Score: 70%
Practice
A patient diagnosed with heart failure (HF) and taking an angiotensin-converting enzyme (ACE) inhibitor, has developed fibrotic changes in the heart and vessels. Which type of medication will the provider order to counter this development?
Correct answer
D
Rationale
The correct answer is D: Aldosterone antagonist. In heart failure, aldosterone contributes to fibrotic changes in the heart and vessels. Aldosterone antagonists like spironolactone or eplerenone can counteract this development by blocking the effects of aldosterone, reducing fibrosis, and improving cardiac function. Beta blockers (A) help in HF by reducing workload on the heart, ARBs (B) block the effects of angiotensin II but do not directly target aldosterone, DRIs (C) inhibit renin production but do not directly block aldosterone effects.